ReGeneraTing Agents (rgta(®)) technology combined with antibiotics improves outcomes for infections in the upper limb

A matrix therapy agent marketed as CACIPLIQ20(®) showed marked improvement in the healing rate of hand infections, including functional recovery. It can be used at both earlier and later stages to promote faster healing and prevent an adverse outcome.

Detalles Bibliográficos
Autores principales: Roohi, Sharifah Ahmad, Keuylian, Zela, Barritault, Denis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7981774/
https://www.ncbi.nlm.nih.gov/pubmed/33768787
http://dx.doi.org/10.1002/ccr3.3645
_version_ 1783667584428670976
author Roohi, Sharifah Ahmad
Keuylian, Zela
Barritault, Denis
author_facet Roohi, Sharifah Ahmad
Keuylian, Zela
Barritault, Denis
author_sort Roohi, Sharifah Ahmad
collection PubMed
description A matrix therapy agent marketed as CACIPLIQ20(®) showed marked improvement in the healing rate of hand infections, including functional recovery. It can be used at both earlier and later stages to promote faster healing and prevent an adverse outcome.
format Online
Article
Text
id pubmed-7981774
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-79817742021-03-24 ReGeneraTing Agents (rgta(®)) technology combined with antibiotics improves outcomes for infections in the upper limb Roohi, Sharifah Ahmad Keuylian, Zela Barritault, Denis Clin Case Rep Case Reports A matrix therapy agent marketed as CACIPLIQ20(®) showed marked improvement in the healing rate of hand infections, including functional recovery. It can be used at both earlier and later stages to promote faster healing and prevent an adverse outcome. John Wiley and Sons Inc. 2021-01-27 /pmc/articles/PMC7981774/ /pubmed/33768787 http://dx.doi.org/10.1002/ccr3.3645 Text en © 2021 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Reports
Roohi, Sharifah Ahmad
Keuylian, Zela
Barritault, Denis
ReGeneraTing Agents (rgta(®)) technology combined with antibiotics improves outcomes for infections in the upper limb
title ReGeneraTing Agents (rgta(®)) technology combined with antibiotics improves outcomes for infections in the upper limb
title_full ReGeneraTing Agents (rgta(®)) technology combined with antibiotics improves outcomes for infections in the upper limb
title_fullStr ReGeneraTing Agents (rgta(®)) technology combined with antibiotics improves outcomes for infections in the upper limb
title_full_unstemmed ReGeneraTing Agents (rgta(®)) technology combined with antibiotics improves outcomes for infections in the upper limb
title_short ReGeneraTing Agents (rgta(®)) technology combined with antibiotics improves outcomes for infections in the upper limb
title_sort regenerating agents (rgta(®)) technology combined with antibiotics improves outcomes for infections in the upper limb
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7981774/
https://www.ncbi.nlm.nih.gov/pubmed/33768787
http://dx.doi.org/10.1002/ccr3.3645
work_keys_str_mv AT roohisharifahahmad regeneratingagentsrgtatechnologycombinedwithantibioticsimprovesoutcomesforinfectionsintheupperlimb
AT keuylianzela regeneratingagentsrgtatechnologycombinedwithantibioticsimprovesoutcomesforinfectionsintheupperlimb
AT barritaultdenis regeneratingagentsrgtatechnologycombinedwithantibioticsimprovesoutcomesforinfectionsintheupperlimb

Ejemplares similares